Teva wiped out $6.1 billion and cut forecasts for 2017

Teva Pharmaceutical Industries said on Thursday it would continue to pursue a breach of contract suit against the former owners of its Rimsa plant in Mexico after the Supreme Court of the State of New York rejected More...

Teva acquires Mexican Rimsa pharmaceutical for $2.3 billion

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is acquiring Rimsa,  an independent pharmaceutical company in Mexico with a portfolio of products and patents in Latin America and Europe More...